Fosinoprilat alleviates lipopolysaccharide (LPS)-induced inflammation by inhibiting TLR4/NF-κB signaling in monocytes. [electronic resource]
Producer: 20140320Description: 182-6 p. digitalISSN:- 1090-2163
- Angiotensin-Converting Enzyme Inhibitors -- pharmacology
- Blotting, Western
- Cell Line
- Flow Cytometry
- Fosinopril -- analogs & derivatives
- Humans
- Inflammation -- drug therapy
- Interleukin-1beta -- immunology
- Interleukin-6 -- immunology
- Monocytes
- NF-kappa B -- antagonists & inhibitors
- RNA, Messenger -- chemistry
- Real-Time Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Toll-Like Receptor 4 -- antagonists & inhibitors
- Tumor Necrosis Factor-alpha -- immunology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.